Hepion Pharmaceuticals Inc (HEPA) FinancialsHEPAFinancialHepion Pharmaceuticals Inc

Evaluating the bottom line, Hepion Pharmaceuticals Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -409.72%, provide a clear picture of how effectively HEPA converts its operational activities into shareholder value.

In the context of the broader market, HEPA competes directly with industry leaders such as AZTR and NLSP. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, HEPA's gross margin of N/A stands against AZTR's N/A and NLSP's N/A. Such benchmarking helps identify whether Hepion Pharmaceuticals Inc is trading at a premium or discount relative to its financial performance.